Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21)

Genes Chromosomes and Cancer

Volumn 27, Issue 3, 2000, Pages 229-238

  Shimizu, Seiichi ^a,b   Suzukawa, Kazumi ^b   Kodera, Takao ^a   Nagasawa, Toshiro ^b   Abe, Tsukasa ^b   Taniwaki, Masafumi ^c   Yagasaki, Fumiharu ^d   Tanaka, Hideo ^e   Fujisawa, Shin ^f   Johansson, Bertil ^g   Ahlgren, Tomas ^g   Yokota, Jun ^a   Morishita, Kazuhiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f YOKOSUKA KYOSAI HOSPITAL   (Japan)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CHROMOSOME 1P; CHROMOSOME 3Q; CHROMOSOME TRANSLOCATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE LOCUS; GENETIC ANALYSIS; HUMAN; LEUKEMIA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS;

AGED; AGED, 80 AND OVER; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 3; FATAL OUTCOME; HEMATOLOGIC NEOPLASMS; HUMANS; HYBRID CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033968350     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200003)27:3<229::AID-GCC2>3.0.CO;2-0     Document Type: Article

References (31)

1. Asou H, Suzukawa K, Kita K, Nakase K, Ueda H, Morishita K, Kamada N. 1996. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis. Br J Haematol 93:68-74.
2. Bitter MA, Neilly ME, Le Beau MM, Pearson MG, Rowley JD. 1985. Rearrangements, of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood 66:1362-1370.
3. Bloomfield CD, Garson OM, Volin L, Khuutila S, de la Chapelle A. 1985. t(1;3)(p36;q21) in acute nonlymphocytic leukemia: a new cytogenetic-clinicopathologic association. Blood 66:1409-1413.
4. Buyse IM, Takahashi EI, Huang S. 1996. Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics 34:119-121.
5. Cuneo A, Van Orshoven A, Michaux JL, Boogaerts M, Louwagie A, Doyen C, Dal Cin P, Fagioli F, Castoldi G, Van den Berghe H. 1990. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types. Br J Haematol 75:346-354.
6. Grigg AP, Gascoyne RD, Phillips GL, Horsman DE. 1993. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 83:158-165.
7. Inwards DJ, Habermann TM, Banks PM, Colgan JP, Dewald GW. 1990. Cytogenetic findings in 21 cases of peripheral T-cell lymphoma. Am J Hematol 35:88-95.
8. Juneja S, Lukeis R, Tan L, Cooper I, Szelag G, Parkin JD, Ironside P, Garson OM. 1990. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations. Br J Haematol 76:231-237.
9. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
10. Lawler SD, Khokhar MT, Davies H, Williams GJ, Powles R. 1990. Cytogenetic studies of leukemic recurrence in recipients of bone marrow allografts. Cancer Genet Cytogenet 47:249-263.
11. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432.
12. Lozzio CB, Lozzio BB. 1975. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321-334.
13. MacLaren DC, Clarke S. 1996. Rapid mapping of genomic P1 clones: the mouse L-isoaspartyl/D-aspartyl methyltransferase gene. Genomics 35:299-307.
14. Marsden KA, Pearse AM, Collins GG, Ford DS, Heard S, Kimber RI. 1992. Acute leukemia with t(1;3)(p36:q21), evolution to t(1;3)(p36; q21), t(14:17)(q32;q21), and loss of red cell A and Le(b) antigens. Cancer Genet Cytogenet 64:80-85.
15. Martin P, Papayannopoulou T. 1982. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 216:1233-1235.
16. Matsuo Y, Adachi T, Tsubota T, Imanishi J, Minowada J. 1991. Establishment and characterization of a novel megakaryoblastic cell line, MOLM-1, from a patient with chronic myelogenous leukemia. Hum Cell 4:261-264.
17. Minowada J, Takeuchi J, Drexler HG, Warzynski M, Sandberg AA. 1985. An NK-cell and T-all antigen-positive T-cell line (MOLT-15) derived from a patient with acute myelomonoblastic leukemia. Proc AACR 26:24.
18. Moir DJ, Jones PA, Pearson J, Duncan JR, Cook P, Buckle VJ. 1984. A new translocation, t(1;3) (p36;q21), in myelodysplastic disorders. Blood 64:553-555.
19. Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP. 1998. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 92:3405-3409.
20. Olah E, Balogh E, Kovacs I, Kiss A. 1989. Abnormalities of chromosome 1 in relation to human malignant diseases. Cancer Genet Cytogenet 43:179-194.
21. Oval J, Jones OW, Montoya M, Taetle R. 1990. Characterization of a factor-dependent acute leukemia cell line with translocation (3:3)(q21;q26). Blood 76:1369-1374.
22. Panani AD, Ferti-Passantonopoulou A, Economopoulos T, Raptis S. 1990. Translocation (1;3)(p36;q21) in secondary leukemia. Cancer Genet Cytogenet 50:165-167.
23. Pekarsky Y, Rynditch A, Wieser R, Fonatsch C, Gardiner K. 1997. Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site 1 in leukemia. Cancer Res 57:3914-3919.
24. Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F, Picard F, Guesnu M, Leboeuf D, Melle J, Drefus F, Flandrin G, Macintyre E. 1995. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias. Blood 85:1313-1322.
25. Rynditch A, Pekarsky Y, Schnittger S, Gardiner K. 1997. Leukemia breakpoint region in 3q21 is gene rich. Gene 193:49-57.
26. Sato Y, Murai M, Tsunoda J, Komatsu N, Muroi K, Yoshida M, Motoyoshi K, Sakamoto S, Miura Y. 1991. Second relapse of acute promyelocytic leukemia (ANLL-M3) with t(15;17) and t(1;3)(p36; q21). Cancer Genet Cytogenet 57:53-58.
27. Secker-Walker LM, Mehta A, Bain B. 1995. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom cancer cytogenetic group study. Br J Haematol 91:490-501.
28. Suzukawa K, Parganas E, Gajjar A, Abe T, Takahashi S, Tani K, Asano S, Asou H, Kamada N, Yokota J, Morishita K, Ihle JN. 1994. Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood 84:2681-2688.
29. Ueda Y, Matsuda F, Misawa S, Taniwaki M. 1996. Tumor-specific rearrangements of the immunoglobulin heavy-chain gene in B-cell non-Hodgkin's lymphoma detected by in situ hybridization. Blood 87:292-298.
30. Welborn JL, Lewis JP, Jenks H, Walling P. 1987. Diagnostic and prognostic significance of t(1:3)(p36;q21) in the disorders of hematopoiesis. Cancer Genet Cytogenet 28:277-285.
31. Werner M, Maschek H, Kaloutsi V, Choritz H, Georgii A. 1992. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance. Virchows Arch A Pathol Anat Histopathol 421:47-52.